|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Partnership revenue | |||||
| Product revenue | |||||
| Total revenue | |||||
| Expenses: | |||||
| Cost of product revenues | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total expenses | |||||
| Loss from operations | |||||
| Other (expense) income: | |||||
| Interest income, net | |||||
| Interest (expense) income, net | |||||
| Loss on fair value adjustment of warrant liability | |||||
| Loss on debt extinguishment | |||||
| Change in the fair value of derivative liability | |||||
| Loss on fair value of strategic investments | |||||
| Other expense | |||||
| Total other (expense) income | |||||
| Net loss | |||||
| Unrealized gain on marketable securities | |||||
| Comprehensive loss | |||||
| Adjustment to carrying value of Series A Preferred Stock | |||||
| Net loss attributable to common stockholders | |||||
| Net loss attributable to common stockholders per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares used in computing net loss attributable to common stockholders per share, basic (in shares) | |||||
| Weighted-average shares used in computing net loss attributable to common stockholders per share, diluted (in shares) | |||||
Loading...